Financials Enfusion, Inc.

Equities

ENFN

US2928121043

Software

Market Closed - Nyse 16:00:02 2024-05-01 EDT 5-day change 1st Jan Change
9.51 USD +2.15% Intraday chart for Enfusion, Inc. +2.26% -1.96%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 1,373 667.1 856.3 846.1 - -
Enterprise Value (EV) 1 1,309 604.6 820.7 790 753.1 712.5
P/E ratio -9.27 x -96.7 x 139 x 77.2 x 45.7 x 48 x
Yield - - - - - -
Capitalization / Revenue 12.3 x 4.44 x 4.91 x 4.12 x 3.48 x 2.97 x
EV / Revenue 11.7 x 4.02 x 4.7 x 3.84 x 3.1 x 2.5 x
EV / EBITDA 57.1 x 30.7 x 26.1 x 18.3 x 13.2 x 9.81 x
EV / FCF -157 x 97.1 x 51.4 x 32.4 x 16.4 x -
FCF Yield -0.64% 1.03% 1.95% 3.09% 6.09% -
Price to Book 42.8 x 17 x 23.1 x 8.3 x 7.37 x 5.49 x
Nbr of stocks (in thousands) 65,583 68,986 88,280 90,877 - -
Reference price 2 20.94 9.670 9.700 9.510 9.510 9.510
Announcement Date 22-03-24 23-03-07 24-03-12 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 79.56 111.7 150.3 174.5 205.5 243.2 284.6
EBITDA 1 - 22.91 19.72 31.47 43.07 57.2 72.64
EBIT 1 - -274.7 13.03 19.41 32.55 44.91 58.15
Operating Margin - -245.9% 8.67% 11.12% 15.84% 18.46% 20.44%
Earnings before Tax (EBT) 1 - -281.7 -12.19 11.48 14.98 24.65 -
Net income 1 4.061 -282.2 -13.26 6.025 19.8 30.69 -
Net margin 5.1% -252.68% -8.82% 3.45% 9.63% 12.62% -
EPS 2 - -2.260 -0.1000 0.0700 0.1231 0.2079 0.1982
Free Cash Flow 1 - -8.332 6.225 15.96 24.38 45.9 -
FCF margin - -7.46% 4.14% 9.15% 11.86% 18.87% -
FCF Conversion (EBITDA) - - 31.57% 50.72% 56.6% 80.25% -
FCF Conversion (Net income) - - - 264.95% 123.1% 149.57% -
Dividend per Share 2 - - - - - - -
Announcement Date 21-09-17 22-03-24 23-03-07 24-03-12 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 29.04 31.85 34.14 36.54 39.15 40.52 40.97 42.72 44.36 46.49 47.62 49.89 52.4 55.62 57.93
EBITDA 1 5.89 3.192 2.088 5.428 5.435 6.764 5.703 7.954 8.028 9.787 7.921 10.46 11.29 13.38 12.16
EBIT 1 4.903 -291.3 0.311 3.762 3.774 5.577 3.532 5.085 5.251 5.538 5.635 7.878 8.599 10.49 9.295
Operating Margin 16.88% -914.46% 0.91% 10.3% 9.64% 13.76% 8.62% 11.9% 11.84% 11.91% 11.84% 15.79% 16.41% 18.87% 16.04%
Earnings before Tax (EBT) 1 3.447 -294 -12.37 -3.906 2.885 1.206 5.09 1.186 3.028 2.18 -0.887 4.463 5.288 6.138 2.575
Net income 1 3.293 -293.9 -7.265 -2.422 1.539 0.788 2.945 0.629 1.828 0.623 -0.8767 3.929 4.652 7.074 2.575
Net margin 11.34% -922.66% -21.28% -6.63% 3.93% 1.94% 7.19% 1.47% 4.12% 1.34% -1.84% 7.87% 8.88% 12.72% 4.44%
EPS 2 0.0500 -2.260 -0.1000 -0.0300 0.0200 0.0100 0.0400 0.0100 0.0200 0.0100 0.004660 0.0294 0.0334 0.0519 0.0269
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 21-12-02 22-03-24 22-05-12 22-08-09 22-11-10 23-03-07 23-05-09 23-08-08 23-11-07 24-03-12 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 64.4 62.5 35.6 56.1 93 134
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -8.33 6.23 16 24.4 45.9 -
ROE (net income / shareholders' equity) - - -15.1% 20.3% 32.1% 28.7% 25.6%
ROA (Net income/ Total Assets) - - - 10.3% 23.9% 25.9% -
Assets 1 - - - 58.27 82.88 118.3 -
Book Value Per Share 2 - 0.4900 0.5700 0.4200 1.150 1.290 1.730
Cash Flow per Share 2 - -0 0.1700 0.2000 0.2600 0.3300 -
Capex 1 - 8.01 7.93 9.67 9.58 10.8 14.1
Capex / Sales - 7.17% 5.28% 5.54% 4.66% 4.43% 4.94%
Announcement Date 21-09-17 22-03-24 23-03-07 24-03-12 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
9.51 USD
Average target price
9.821 USD
Spread / Average Target
+3.27%
Consensus
  1. Stock Market
  2. Equities
  3. ENFN Stock
  4. Financials Enfusion, Inc.